Drug intelligence / Profile preview

gechai decoction

Development stage: Preclinical
Lead developer: Hangzhou Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Gechai decoction is a Traditional Chinese Medicine (TCM) herbal formula currently under investigation for its antipyretic effects and safety in the treatment of COVID-19. As a decoction, it is a combination of various herbs prepared by boiling them in water. The specific herbal components and their detailed mechanisms of action are not publicly detailed in the provided context, but its use in a clinical trial suggests a potential role in alleviating fever and other symptoms associated with viral infections like COVID-19.

Other names: Gechai Tangfang

Beyond the preview

Go deeper on gechai decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on gechai decoction.

Explore the full profile